• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

旁分泌血管内皮生长因子/血管内皮钙黏蛋白对卵巢癌通透性的作用

Paracrine VEGF/VE-cadherin action on ovarian cancer permeability.

作者信息

Hu Limin, Ferrara Napoleone, Jaffe Robert B

机构信息

Center for Reproductive Sciences, University of California, San Francisco, 505 Parnassus Avenue, HSW 1450, San Francisco, CA 94143-0556, USA.

出版信息

Exp Biol Med (Maywood). 2006 Nov;231(10):1646-52. doi: 10.1177/153537020623101010.

DOI:10.1177/153537020623101010
PMID:17060686
Abstract

Ascites formation associated with neoplasms is most likely due to increased vascular permeability, a process in which vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) plays a pivotal role. We hypothesized that tumor-derived VEGF/VPF modulates ascites formation through a paracrine effect on both tumor and peritoneal vessels. We investigated human vascular endothelial permeability using a newly developed dual-chamber permeability assay by co-culturing human umbilical vein cells with and without ovarian cancer cell lines (OVCAR-3, Hey-A8, and OCC-1) in the presence or absence of a human VEGF monoclonal antibody and VE-cadherin function-blocking antibody. This method permits determination of mechanisms by which substances released from neoplasms and other sources of vascular endothelial cell secretagogues modulate vascular permeability and likely other pathologic states.

摘要

与肿瘤相关的腹水形成很可能是由于血管通透性增加,在这个过程中血管内皮生长因子/血管通透因子(VEGF/VPF)起着关键作用。我们推测肿瘤来源的VEGF/VPF通过对肿瘤和腹膜血管的旁分泌作用来调节腹水形成。我们通过一种新开发的双室通透性测定法来研究人类血管内皮通透性,该方法是在有或无人类VEGF单克隆抗体和VE-钙黏蛋白功能阻断抗体的情况下,将人脐静脉细胞与卵巢癌细胞系(OVCAR-3、Hey-A8和OCC-1)共培养。这种方法能够确定肿瘤及其他血管内皮细胞分泌源释放的物质调节血管通透性以及可能的其他病理状态的机制。

相似文献

1
Paracrine VEGF/VE-cadherin action on ovarian cancer permeability.旁分泌血管内皮生长因子/血管内皮钙黏蛋白对卵巢癌通透性的作用
Exp Biol Med (Maywood). 2006 Nov;231(10):1646-52. doi: 10.1177/153537020623101010.
2
Does VEGF facilitate local tumor growth and spread into the abdominal cavity by suppressing endothelial cell adhesion, thus increasing vascular peritoneal permeability followed by ascites production in ovarian cancer?血管内皮生长因子(VEGF)是否通过抑制内皮细胞黏附促进局部肿瘤生长并扩散至腹腔,从而增加血管腹膜通透性,进而导致卵巢癌腹水生成?
Mol Cancer. 2016 Feb 12;15:13. doi: 10.1186/s12943-016-0497-3.
3
Expression of vascular endothelial growth factor and E-cadherin in human ovarian cancer: association with ascites fluid accumulation and peritoneal dissemination in mouse ascites model.血管内皮生长因子和E-钙黏蛋白在人卵巢癌中的表达:与小鼠腹水模型中腹水积聚和腹膜播散的关系
Jpn J Cancer Res. 2002 Jun;93(6):644-51. doi: 10.1111/j.1349-7006.2002.tb01302.x.
4
Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody.抗血管内皮生长因子/血管通透因子抗体诱导的已建立人肿瘤异种移植模型中随时间变化的血管消退和通透性改变
Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14765-70. doi: 10.1073/pnas.93.25.14765.
5
Inhibition of malignant ascites and growth of human ovarian carcinoma by oral administration of a potent inhibitor of the vascular endothelial growth factor receptor tyrosine kinases.口服血管内皮生长因子受体酪氨酸激酶强效抑制剂对人卵巢癌恶性腹水及生长的抑制作用
Int J Oncol. 2000 Mar;16(3):445-54. doi: 10.3892/ijo.16.3.445.
6
Vascular endothelial cadherin regulates vascular permeability: Implications for ovarian hyperstimulation syndrome.血管内皮钙黏蛋白调节血管通透性:对卵巢过度刺激综合征的影响。
J Clin Endocrinol Metab. 2007 Jan;92(1):314-21. doi: 10.1210/jc.2006-1231. Epub 2006 Oct 10.
7
Vascular endothelial growth factor immunoneutralization plus Paclitaxel markedly reduces tumor burden and ascites in athymic mouse model of ovarian cancer.血管内皮生长因子免疫中和联合紫杉醇可显著减轻卵巢癌无胸腺小鼠模型的肿瘤负荷和腹水。
Am J Pathol. 2002 Nov;161(5):1917-24. doi: 10.1016/S0002-9440(10)64467-7.
8
Ultrastructural localization of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) to the abluminal plasma membrane and vesiculovacuolar organelles of tumor microvascular endothelium.血管通透因子/血管内皮生长因子(VPF/VEGF)在肿瘤微血管内皮细胞的无腔质膜和囊泡-液泡细胞器中的超微结构定位。
J Histochem Cytochem. 1995 Apr;43(4):381-9. doi: 10.1177/43.4.7534783.
9
Urocortin increased LPS-induced endothelial permeability by regulating the cadherin-catenin complex via corticotrophin-releasing hormone receptor 2.尿皮质素通过促肾上腺皮质激素释放激素受体 2 调节钙黏蛋白-连环蛋白复合物增加脂多糖诱导的内皮通透性。
J Cell Physiol. 2013 Jun;228(6):1295-303. doi: 10.1002/jcp.24286.
10
VEGF induces ascites in ovarian cancer patients via increasing peritoneal permeability by downregulation of Claudin 5.VEGF 通过下调 Claudin 5 增加腹膜通透性诱导卵巢癌患者腹水形成。
Gynecol Oncol. 2012 Oct;127(1):210-6. doi: 10.1016/j.ygyno.2012.05.002. Epub 2012 May 8.

引用本文的文献

1
Biology-driven therapy advances in high-grade serous ovarian cancer.基于生物学的治疗方法在高级别浆液性卵巢癌中的进展。
J Clin Invest. 2024 Jan 2;134(1):e174013. doi: 10.1172/JCI174013.
2
Mechanisms of tumor cell extravasation in an in vitro microvascular network platform.肿瘤细胞在体外微血管网络平台中的渗出机制。
Integr Biol (Camb). 2013 Oct;5(10):1262-71. doi: 10.1039/c3ib40149a.
3
Differential roles of uPAR in peritoneal ovarian carcinomatosis.uPAR 在腹膜卵巢癌转移中的差异作用。
Neoplasia. 2012 Apr;14(4):259-70. doi: 10.1593/neo.12442.
4
ABT-510 induces tumor cell apoptosis and inhibits ovarian tumor growth in an orthotopic, syngeneic model of epithelial ovarian cancer.在原位同基因上皮性卵巢癌模型中,ABT-510可诱导肿瘤细胞凋亡并抑制卵巢肿瘤生长。
Mol Cancer Ther. 2009 Jan;8(1):64-74. doi: 10.1158/1535-7163.MCT-08-0864.